ArticleArchives of medical science : AMS2020

State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2.

J Francis Borgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.